Displaying 1 - 1 of 1
| Active Ingredient | ANASTROZOLE |
| Therapeutic Class | ANTINEOPLASTICS - Aromatase Inhibitor |
| Indications | Advanced or locally advanced breast cancer, adjuvant treatment in hormone receptor-positive early breast cancer in postmenopausal women. |
| Caution | Gastrointestinal disturbances, hot flushes, dizziness, drowsiness, headache, rash, hair thinning, vaginal dryness or bleeding, myalgia, arthralgia, carpal tunnel syndrome, and bone pain and/or More ... |
| Dose Range | Adult: 1 mg once daily with or without food. |
| Drug Interactions |
Estrogen-containing Therapies Tamoxifen |
| Pregnancy | Avoid in pregnancy. This drug can cause fetal toxicity when administered to preg More ... |
| Breast Feeding | Avoid. |